TransMedics Group Inc (TMDX) (Q2 2026) Earnings Call Highlights: Record Revenue and Strategic ...
Kort samengevat
TransMedics Group Inc (TMDX) posts 21% revenue growth to $190 million, raises full-year guidance, and advances key clinical programs despite margin pressure from strategic investments.
Verder lezen bij de bron
Bekijk het volledige nieuwsbericht rechtstreeks bij Yahoo Finance.
Lees het volledige bericht ↗